Trial Profile

Efficacy and Safety of Paliperidone ER in Patients With First Episode Psychosis: an Open-label, Prospective Multi-center Study.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 18 Jan 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Paliperidone (Primary)
Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
Focus Therapeutic Use

Most Recent Events

30 Jul 2015 Status changed from recruiting to completed as per Clinical Trials Register record.
10 Feb 2012 Planned End Date changed from 1 Jun 2011 to 1 Mar 2013 as reported by ClinicalTrials.gov.
25 Aug 2011 New source identified and integrated (Korean Clinical Trials Register record KCT0000009).

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com